NCT06340620 EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
| NCT ID | NCT06340620 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Orlando Health, Inc. |
| Condition | Pancreatic Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2024-03-25 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2024-03-25 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomized trial to compare the standard echoendoscope with the newly developed EndoSound Visual System in the evaluation of lesions in the gastrointestinal tract.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Any patient undergoing EUS examination for evaluation of the pancreas, bile duct, mediastinal or intraabdominal lymph nodes, or luminal lesions in the esophagus, stomach, duodenum or colon. Exclusion Criteria: * Age \< 18 years. * Unable to obtain consent for the procedure from either the patient or LAR. * Intrauterine pregnancy.
Contact & Investigator
Ji Young Bang, MD MPH
PRINCIPAL INVESTIGATOR
Orlando Health, Digestive Health Institute
Frequently Asked Questions
Who can join the NCT06340620 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Pancreatic Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06340620 currently recruiting?
Yes, NCT06340620 is actively recruiting participants. Contact the research team at jiyoung.bang@orlandohealth.com for enrollment information.
Where is the NCT06340620 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT06340620 clinical trial?
NCT06340620 is sponsored by Orlando Health, Inc.. The principal investigator is Ji Young Bang, MD MPH at Orlando Health, Digestive Health Institute. The trial plans to enroll 140 participants.